Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Domo, Inc.
  6. News
  7. Summary
    DOMO   US2575541055


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Domo : Business Leaders Describe Their ‘Modern BI for All' Journeys

07/06/2021 | 11:08am EDT

Why do senior representatives of leading companies in the Life Sciences sector view Modern BI for All as a continuous journey? Where are each of their organizations in that journey? And what advice do they have for other business leaders-in any industry-who are either on the same journey or contemplating how and when to embark upon such a path?

Those questions were among the many addressed during a recent Domo-hosted roundtable discussion featuring data and analytics evangelists at Merck and Astellas Pharma. And the answers they provided made for the kind of guidance anyone with an interest in challenging traditional approaches to BI is seeking.

From the start, the panelists made clear that their respective enterprise's Modern BI for All journey began where most do: with identifying where all their meaningful data lived-including third-party data and data from offline systems-and then figuring out a way to bring it all together.

For Merck and Astellas Pharma, the latter portion of that critical first step was made in partnership with Domo, whose Modern BI platform enabled them to build high-value dashboards and cards that anyone with permission within their organizations can easily access from any device.

'With that data in our hands, we could do something with it,' said Vince Kelly, Astellas Pharma's head of digital marketing and customer experience. 'We could model it, and we could get insights out of it.'

Establishing a level of data agility-a pillar of Modern BI for All-meant Merck and Astellas Pharma could then create real-time reports at scale and even move data from Domo into other platforms.

Was getting to such a point easy? Not exactly. But as Janine O'Connor-who oversees technology, data, and analytics efforts related to Merck's travel and meetings operations-said, there's just no way around it.

'It can take a few iterations to get the data correct so it can be merged,' she explained,' and some data isn't refreshed at the same frequency as other data. But we put notes in dashboards so users are aware of that, and we just keep communicating and striving to improve that foundation.'

As far as how another component of Modern BI for All-data literacy-has evolved at Merck and Astellas Pharma since they began their business intelligence transformation initiatives, Phil Hodes put Merck at 'about a 3 or 4 (on a scale of 0-10)' while Vince answered the question using a baseball analogy.

'Everyone thinks they're going to get nirvana out of the gates,' Vince said, 'but the truth is, you won't get anywhere without at-bats. People need more reps so they can become more comfortable. And that's what's happening for us.

'Getting everyone more involved in data has changed how we plan and go to market. We still have a ways to go, of course-we're still only in Year 3 of our journey-but the mentality of 'How quickly can we make adjustments?' is definitely starting to flip.'

In other words, developing a culture that understands how to look at data is opening the door at Astellas Pharma to intelligent action, which is the third and final-and perhaps most important-element to Modern BI for All. It's the element that separates businesses, because it's where the real value in data lives.

'For us, that means changing the question from 'What?' to 'What's next?'' said Phil, who is in charge of process excellence and enterprise projects within Merck's travel and meetings division. 'It's what will allow us to go beyond seeing 'What has happened?' to determining 'What can or should we do in the future?'

'When should we do a digital event? Where should we hold a meeting? Whom should we invite? That's where a lot of our focus is right now, because there's real decision-making power in having that kind of insight and knowledge.'

To learn about all the ways Domo helps organizations in any sector get on the fast track to Modern BI for All, click here. To watch the roundtable discussion between Phil, Janine, and Vince, go here.


Domo Inc. published this content on 06 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 July 2021 15:07:06 UTC.

ę Publicnow 2021
All news about DOMO, INC.
09/16DOMO : How to Meet the 3 Biggest Enterprise-Scaling Challenges
09/16DOMO : Introduces Sandbox to Help Customers More Easily Scale BI and Analytics Across the ..
09/10DOMO : Named to Constellation ShortList™ for Marketing Analytics Solutions
09/09DOMO : Quarterly Report (SEC Filing - 10-Q)
09/09DOMO : Management's Discussion and Analysis of Financial Condition and Results of Operatio..
09/08DOMO : Named to Constellation ShortList™ for Cloud-Based Business Intelligence and A..
09/07DOMO : Executives to Participate in Upcoming Investor Conferences
08/27DOMO : Submission of Matters to a Vote of Security Holders (form 8-K/A)
08/27DOMO : Cowen Adjusts Domo's Price Target to $110 From $100, Keeps Outperform Rating
08/27DOMO : Morgan Stanley Adjusts Domo's Price Target to $98 From $91, Reiterates Overweight R..
More news
Analyst Recommendations on DOMO, INC.
More recommendations
Financials (USD)
Sales 2022 255 M - -
Net income 2022 -86,6 M - -
Net Debt 2022 14,3 M - -
P/E ratio 2022 -29,8x
Yield 2022 -
Capitalization 2 719 M 2 719 M -
EV / Sales 2022 10,7x
EV / Sales 2023 8,98x
Nbr of Employees 756
Free-Float 85,8%
Chart DOMO, INC.
Duration : Period :
Domo, Inc. Technical Analysis Chart | DOMO | US2575541055 | MarketScreener
Technical analysis trends DOMO, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 5
Last Close Price 84,56 $
Average target price 106,25 $
Spread / Average Target 25,7%
EPS Revisions
Managers and Directors
Joshua G. James Chairman & Chief Executive Officer
Bruce C. Felt Chief Financial Officer
Daren Thayne Chief Technology Officer
Catherine Wong Chief Product Officer & Executive VP-Engineering
Suyesh Karki Chief Information Security Officer
Sector and Competitors
1st jan.Capi. (M$)
DOMO, INC.32.60%2 719
SAP SE13.08%167 462
INTUIT INC.52.14%157 825
SERVICENOW, INC.21.05%132 019
DOCUSIGN, INC.22.52%53 580